Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer

Autor: Arunachalam, Ashwini, Li, Haojie, Bittoni, Marisa A., Camacho, Ramon, Cao, Xiting, Zhong, Yichen, Lubiniecki, Gregory M., Carbone, David P.
Zdroj: In Clinical Lung Cancer September 2018 19(5):e783-e799
Databáze: ScienceDirect